Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that is highly prevalent worldwide. Interleukin (IL)-10 can effectively inhibit negative cascades such as the production of inflammatory mediators (inducible nitric oxide synthase [iNOS], cyclooxygenase-2), accumulation of inflammatory infiltrates (macrophages, eosinophils, neutrophils), toxicity (lower T cell subsets), and secretion of pro-inflammatory cytokines (IL-1β, TNF-α) in tissues such as the spleen, mesenteric lymph nodes (MLN), Peyer's patch (PP), and colon. In this study, we investigated whether chlorogenic acid (CHA) can regulate inflammation in IL-10 knockout (KO) mice used as an IBD animal model. CHA significantly increased the ratio of CD4+/CD8+, T cell subsets in PP, and MLN of IL-10 KO mice. In addition, CHA also morphologically attenuated colon inflammation in IL-10 KO mice. We demonstrated that CHA significantly reduced the expression levels of iNOS, IL-1β, TNF-α, which were highly expressed in IL-10 KO mice. Therefore, CHA may provide beneficial effects for improving IBD by decreasing inflammations.
MichalskaA, LysiakG: Bioactive compounds of blueberries: Post-harvest factors influencing the nutritional value of products. Int J Mol Sci, 2015; 16:18642–18663.
3.
YeY, PangZ, ChenW, JuS, ZhouC: The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med, 2015; 8:22529–22542.
4.
ActisGC, PellicanoR, RosinaF: Inflammatory bowel diseases: Current problems and future tasks. World J Gastrointest Pharmacol Ther, 2014; 5:169–174.
5.
MijanMA, LimBO: Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World J Gastroenterol, 2018; 24:2673–2685.
6.
IyerSS, ChengG: Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol, 2012; 32:23–63.
7.
BeebeAM, CuaDJ, de Waal MalefytR: The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev, 2002; 13:403–412.
8.
MosserDM, ZhangX: Interleukin-10: New perspectives on an old cytokine. Immunol Rev, 2008; 226:205–218.
9.
CareyAJ, TanCK, UlettGC: Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAKSTAT, 2012; 1:159–167.
10.
RileyJK, TakedaK, AkiraS, SchreiberRD: Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem, 1999; 274:16513–16521.
11.
DriesslerF, VenstromK, SabatR, AsadullahK, SchotteliusAJ: Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: A role for p50. Clin Exp Immunol, 2004; 135:64–73.
12.
FangH, PengalRA, CaoX, GanesanLP, WewersMD, MarshCB, TridandapaniS: Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J Immunol, 2004; 173:360–366.
13.
PorterKJ, GonipetaB, ParvataneniS, GanesanLP, WewersMD, MarshCB, TridandapaniS: Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. J Cell Physiol, 2010; 225:406–416.
14.
YeMB, BakJP, AnCS, JinHL, KimJM, KweonHJ, ChoiDK, ParkPJ, KimYJ, LimBO: Dietary beta-glucan regulates the levels of inflammatory factors, inflammatory cytokines, and immunoglobulins in interleukin-10 knockout mice. J Med Food, 2011; 14:468–474.
15.
MollazadehH, CiceroAFG, BlessoCN, PirroM, MajeedM, SahebkarA: Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr, 2019; 59:89–101.
16.
HanHE, KimTK, SonHJ, ParkWJ, HanPL: Activation of autophagy pathway suppresses the expression of iNOS, IL6 and cell death of LPS-stimulated microglia cells. Biomol Ther (Seoul), 2013; 21:21–28.
17.
HulmeAC: The isolation of chlorogenic acid from the apple fruit. Biochem J, 1953; 53:337–340.
18.
OngKW, HsuA, TanBK: Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol, 2013; 85:1341–1351.
19.
SuzukiA, YamamotoN, JokuraH, YamamotoM, FujiiA, TokimitsuI, SaitoI: Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens, 2006; 24:1065–1073.
20.
JungHA, ParkJC, ChungHY, KimJ, ChoiJS: Antioxidant flavonoids and chlorogenic acid from the leaves of Eriobotrya japonica. Arch Pharm Res, 1999; 22:213–218.
21.
FranciscoV, CostaG, FigueirinhaA, MarquesC, PereiraP, NevesBM, LopesMC, García-RodríguezC, CruzMT, BatistaMT: Anti-inflammatory activity of Cymbopogon citratus leaves infusion via proteasome and nuclear factor-kappaB pathway inhibition: Contribution of chlorogenic acid. J Ethnopharmacol, 2013; 148:126–134.
22.
PervinM, HasnatMA, LimJH, LeeYM, KimEO, UmBH, LimBO: Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators. J Nutr Biochem, 2016; 28:103–113.
23.
ZhengHCM, LiY, WangY, WeiL, LiaoZ, WangM, MaF, LiaoQ, XieZ: Modulation of gut microbiome composition and function in experimental colitis treated with sulfasalazine. Front Microbiol, 2017; 8:1703.
24.
Kotlyar DSSM, HsiehJ, BlonskiW, GreenwaldDA: Non-pulmonary allergic diseases and inflammatory bowel disease: A qualitative review. World J Gastroenterol, 2014; 20:11023–11032.
25.
LeeTH, ParkS, YooG, JangC, KimM-H, KimSH, KimSY: Demethyleugenol beta-glucopyranoside isolated from agastache rugosa decreases melanin synthesis via down-regulation of MITF and SOX9. J Agric Food Chem, 2016; 64:7733–7742.
26.
LiangN, KittsDD: Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients, 2015; 8:16.
27.
PaloczO, Paszti-GereE, GalfiP, FarkasO: Chlorogenic acid combined with Lactobacillus plantarum 2142 reduced LPS-induced intestinal inflammation and oxidative stress in IPEC-J2 cells. PLoS One, 2016; 11:e0166642.
28.
PriceAB, MorsonBC: Inflammatory bowel disease: The surgical pathology of Crohn's disease and ulcerative colitis. Hum Pathol, 1975; 6:7–29.
VieiraPL, ChristensenJR, MinaeeS, O'NeillEJ, BarratFJ, BoonstraA, BarthlottT, StockingerB, WraithDC, O'GarraA: IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol, 2004; 172:5986–5993.
34.
KobayashiN, NagumoH, AgematsuK: IL-10 enhances B-cell IgE synthesis by promoting differentiation into plasma cells, a process that is inhibited by CD27/CD70 interaction. Clin Exper Immunol, 2002; 129:446–452.
35.
LiMC, HeSH: IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol, 2004; 10:620–625.
36.
DannSM, LeC, ChoudhuryBK, LiuH, SaldarriagaO, HansonEM, CongY, EckmannL: Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium. Infect Immun, 2014; 82:1949–1958.
37.
EngelhardtKR, GrimbacherB: IL-10 in humans: Lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol, 2014; 380:1–18.
38.
BergDJ, ZhangJ, LauricellaDM, MooreSA: Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J Immunol, 2001; 166:2674–2680.
39.
PereiraSR, PereiraR, FigueiredoI, FreitasV, DinisTC, AlmeidaLM: Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model. PLoS One, 2017; 12:e0174116.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
